Staphylococcus aureus proteins and nucleic acids

Details Staphylococcus aureus proteins and nucleic acids Staphylococcus aureus proteins and nucleic acids

2002-03-27

2009-10-27

Mondesi, Robert B (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S190100, C424S184100, C435S252300, C435S069700, C435S069100, C530S350000, C536S023700

Reexamination Certificate

active

07608276

ABSTRACT:
The invention provides proteins fromStaphylococcus aureusincluding amino acid sequences and the corresponding nucleotide sequences. The proteins are useful for vaccines, immunogenic compositions, diagnostics, enzymatic studies and also as targets for antibiotics.

REFERENCES:
patent: 7101692 (2006-09-01), Schneewind et al.
patent: 7410647 (2008-08-01), Foster
patent: 2006/0140979 (2006-06-01), Foster et al.
patent: 2008/0038287 (2008-02-01), Meinke
patent: 0 785 519 (1997-07-01), None
patent: 0786519 (1997-07-01), None
patent: WO 98/18931 (1998-05-01), None
patent: WO 00/06738 (2000-02-01), None
patent: WO 01/16292 (2001-03-01), None
patent: 01/70955 (2001-09-01), None
patent: WO 01/98499 (2001-12-01), None
patent: WO 02/059148 (2002-08-01), None
patent: 02/077183 (2002-10-01), None
patent: 02/102829 (2002-12-01), None
patent: 03/011899 (2003-02-01), None
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976,).
Bowie et al (Science, 1990, 257:1306-1310).
Feng et al 2004, Biochimie 86; 893-901.
Camara et al, Infection and Immunity, 62(9):3688-3695 (1994).
Tettelin et al, Science, 293(5529):498-506.
Partial European Search Report, dated Aug. 1, 2007, in Counterpart European Application No. 07075403.1-2405.
Navarre et al., “Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope,” Microbiology and Molecular Biology Reviews, American Society for Microbiology, US, vol. 63, No. 1, Mar. 1999: 174-229; XP002319594.
Cheung et al., “Surface Proteins ofStaphylococcus aureus,” Review of Infectious Diseases, Chicago, IL, US, vol. 10, No. Suppl. 2, Jul. 1988: S351-S355; XP002020048.
Foster, “Potential for Vaccination against Infections Caused byStaphylococcus aureus,” Vaccine, Butterworth, Scientific. Guildford, GB, vol. 9, No. 4, Apr. 1991: 221-227; XP002020047.
Database Geneseq (Online) Mar. 16, 1999, “Staphylococcus aureauscontig. Seq ID #205” retrieved from EBI accession No. GSN: AAV74516 Database accession No. AAV74516; XP002443354.
Kunst et al., “The complete genome sequence of the gram-positive bacteriumBacillus subtilis,” Nature. Nov. 20, 1997;390(6657):249-56.
Kuroda et al., “Whole genome sequencing of meticillin-resistantStaphylococcus aureus,” Lancet. Apr. 21, 2001;357 (9264):1225-40.
Database EMBL Online Aug. 2, 2000, Kimmerly et al., “Staphylococcus epidermidisstrain SR1 clone strep. 1052f10 genomic sequence” retrieved from EBI, Database accession No. AF270186; XP002224580.

Affiliated with

Also associated with

Rating

Staphylococcus aureus proteins and nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Staphylococcus aureus proteins and nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Staphylococcus aureus proteins and nucleic acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4096093